Clinical Trials Browser

Phase 2 × Glioblastoma × Radiation Dose Hypofractionation × Clear all

NCT06160206 2024-11-19

Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma

Phase 2 Recruiting

Glioblastoma